Skip to main content

Find Clinical Trials

Home
Conditions
Intrahepatic Cholangiocarcinoma

Clinical trial condition

Intrahepatic Cholangiocarcinoma

Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

77 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Intrahepatic Cholangiocarcinoma trial results

Recruiting

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

NCT06505486

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, China

View Trial Details

Recruiting

Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

NCT06298968

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

NCT06296563

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

NCT06098547

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Azienda Ospedale Università di Padova Padova, Italy

View Trial Details

Recruiting

Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)

NCT04556214

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Recruiting

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

NCT04078230

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: The Johns Hopkins Hospital Baltimore, Maryland, United States

China-Japan Friendship Hospital Beijing, Beijing Municipality, China

Chinese PLA General Hospital Beijing, Beijing Municipality, China

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China

View all 13 locations

View Trial Details

Not yet recruiting

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy

NCT07715903

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +26 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not yet recruiting

Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy

NCT07814586

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma

NCT07766187

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Not yet recruiting

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

NCT07432568

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Not specified

View Trial Details